Arab Drug Co
- 82.98 EGP
- 2.58
- 3.21%
Arab Drug Co Stock Overview
View Company ProfileStock Summary
| Last Price (EGP) | 82.98 |
| Prev. Close | 80.400 |
| Day Range | 82.97 - 82.98 |
| 52WK range | |
| Turnover (M EGP) | 0.00 |
| Volume (M) | 0.00 |
| Number of Trades | 3 |
| Market Cap (M EGP) | 275.04 |
| Change in Market Cap (M EGP) | |
| VWAP (EGP) | 0.00 |
| EPS (TTM) | -- |
| EX-Dividend Date | |
| Dividend | |
| Dividend Yield (%) | |
| Beta | |
| 30D Avg Volume | |
| 30D Avg Turnover(M EGP) | |
| Outstanding Shares | |
| Free Float Shares | |
| Free Float % |
Stock Performance
Stock Highlights
| Highest Market Cap | |
| Date of Highest Mkt. Cap | |
| Lowest Market Cap | |
| Date of Lowest Mkt. Cap |
Earnings Progress
News
More Company News
Arab Drug’s OGM approves FY21/22 dividends
Cairo – Mubasher: The ordinary general meeting (OGM) of The Arab Drug Company approved a cash dividend distribution of EGP 4.80 per share to its...
Arab Drug reports lower profits of EGP 43m in four...
Cairo – Mubasher: The initial financial results of The Arab Drug Company indicated an annual plunge in net profits before tax to EGP 42.94 million...
Arab Drug's shareholders approve EGP 5/shr dividend...
Cairo – Mubasher: The ordinary general meeting (OGM) of Arab Drug Company approved a cash dividend of EGP 5 per share for fiscal year (FY) 2020/2021,...
Arab Drug logs EGP 102m profit in FY20/21
Cairo - Mubasher: Arab Drug Company achieved net profits of EGP 102 million in fiscal year (FY) 2020/2021, up by 9.9% year-on-year (YoY) from EGP 92.8...
Arab Drug records 8.5% rise in 11-month profits
Cairo – Mubasher: Arab Drug Company achieved an 8.5% growth in net profits before tax to EGP 122.2 million during the first 11 months of fiscal year...
